DAVI-ANN FRANCIS BROWN: Open Payments
NPI 1245709864 · EAST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 9 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $546 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: TRELEGY ELLIPTA, BREZTRI, MOUNJARO, Auvelity, NURTEC ODT, JARDIANCE, MYFEMBREE, XIFAXAN.
Industry payments across CT — which companies pay providers there.
